knowledge -WSS

knowledge

author：focus 2025-09-28 22:53:28 - browse：49

Illustration of a laptop on top of a TV with a hand sticking out, holding a newspaper. -- coverage from STAT — Adobe

WASHINGTON – If you live in this city, you’re probably awash in pharmacy benefit manager ads — whether you’re listening to an NPR podcast, reading the New York Times, streaming “Yellowstone,” or watching the U.S. Open Golf Championships. It doesn’t matter if it’s 5 a.m., primetime, or 11 p.m.; in between ads for dog joint supplements and the “Barbie” movie, you will inevitably learn about these middlemen of the prescription drug market.

Ads eviscerating and glorifying PBMs have been around for years. But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. Over a half-dozen U.S. House and Senate Committees have started investigating PBMs, advancing bipartisan legislation to increase transparency in the industry; ban PBMs from charging more for a drug than what they pay (and pocketing the difference); and require them to pass all fees, rebates, and other payments they receive to insurers.

Lobbying groups have responded to this legislative push with dueling campaigns in the court of public opinion. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices. On the other side is the industry group PhRMA, which points the finger right back, saying that PBMs are really to blame. Both trade associations have launched ad campaigns worth millions of dollars, blanketing TV, radio, social media, print, and beyond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： FTX founder Sam Bankman

entertainment

WSS

Flagship Pioneering launches a new biotech in two countries

Hospitals use virtual reality to design more inclusive rooms for kids

With clinical trial data readouts, here's how to spot spin

Pediatric cancer treatments threatened by a new FDA policy

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

CDC launches VaccineFinder tool to locate Covid

knowledge

knowledge

hotspot

Heart attack and stroke risk calculators need revising

CDC director unscathed in first congressional testimony

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Judge rejects Trump's counterclaim against E. Jean Carroll

BioMarin wins approval for gene therapy to treat hemophilia A

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Medical records are filled with copy

Biden praises World Series champion Astros for impact off the field during White House celebration

Moonlake's readout produced a cash windfall. Risks remain

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

hotspot

Pediatric cancer treatments threatened by a new FDA policy

Cigna, Humana reportedly in talks to merge

With clinical trial data readouts, here's how to spot spin

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Pediatric cancer treatments threatened by a new FDA policy

Discs beat pads, tampons for heavy menstrual flow, new study shows

Wikipedia

entertainment

Wikipedia

focus